Apimeds Pharmaceuticals US (APUS) Amortizatization of Intangibles (2024 - 2025)
Apimeds Pharmaceuticals US (APUS) reported Amortizatization of Intangibles of $243177.0 for Q4 2025, up 288.35% on a YoY basis from $62618.0 in Q4 2024, and up 24317600.0% quarter-over-quarter from $1.0 in Q3 2025.
Apimeds Pharmaceuticals US (APUS) Amortizatization of Intangibles (2024 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US has reported Amortizatization of Intangibles for 2 years, with the latest figure at $243177.0 in Q4 2025.
- For the quarter ending Q4 2025, Amortizatization of Intangibles rose 288.35% year-over-year to $243177.0; the trailing twelve-month figure through Dec 2025 stood at $283010.0 (up 140.41% YoY), and the FY2025 full-year result was $283010.0, up 140.41% from the prior year.
- Amortizatization of Intangibles for Q4 2025 stood at $243177.0, up from $1.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $243177.0 in Q4 2025, with the low at $1.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Apimeds Pharmaceuticals US | 14.47 Mn | 10.84 Mn | - | 243,177.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 243,177.00 |
| Dec 31, 2025 | 243,177.00 |
| Sep 30, 2025 | 1.00 |
| Sep 30, 2025 | 1.00 |
| Jun 30, 2025 | 13,056.00 |
| Jun 30, 2025 | 13,056.00 |
| Mar 31, 2025 | 26,776.00 |
| Mar 31, 2025 | 26,776.00 |
| Dec 31, 2024 | 62,618.00 |
| Dec 31, 2024 | 62,618.00 |
| Sep 30, 2024 | 22,530.00 |
| Sep 30, 2024 | 22,530.00 |
| Jun 30, 2024 | 13,619.00 |
| Jun 30, 2024 | 13,619.00 |
| Mar 31, 2024 | 18,952.00 |
| Mar 31, 2024 | 18,952.00 |